UPDATE: Covetrus Q2 Adj. EPS $0.26 Beats $0.25 Estimate, Sales $1.22B Miss $1.22B Estimate

8/4/22 9:10:04 AM ET

Other Pharmaceuticals

Health Care

Get the next $CVET alert in real time by email

Covetrus (NASDAQ:CVET) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.25 by 4 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.22 billion which missed the analyst consensus estimate of $1.22 billion by 0.25 percent. This is a 2.35 percent increase over sales of $1.19 billion the same period last year.

Get the next $CVET alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CVET

Date	Price Target	Rating	Analyst
6/13/2022	$22.00	Buy → Hold	Stifel
5/23/2022		Outperform → Mkt Perform	Raymond James
11/18/2021	$19.00	Equal-Weight	Morgan Stanley
11/5/2021	$37.00 → $27.00	Outperform	Raymond James
8/9/2021	$46.00 → $38.00	Overweight	Barclays
8/6/2021	$38.00 → $37.00	Outperform	Raymond James
8/5/2021	$29.00	Neutral	Credit Suisse
7/12/2021	$30.00	Neutral → Buy	Guggenheim

More analyst ratings

$CVET
Press Releases

Fastest customizable press release news feed in the world

Semrush Strengthens Customer Focus with Appointment of Veronique Montreuil as Chief Customer and Data Officer
Semrush (NYSE:SEMR), a leading online visibility management SaaS platform, is pleased to announce that Veronique Montreuil joins the executive team as Chief Customer and Data Officer. With over 20 years of experience in customer success and customer experience, Veronique brings a wealth of expertise to enhance customer relationships and drive growth. In her most recent role as Head of Technology Sales and Customer Success at Covetrus (NASDAQ:CVET), Veronique led a team of 275 professionals, driving operational efficiency, fostering deep customer relationships, and optimizing customer value through strategic initiatives and process improvements. She held prior roles at companies INAP (NASD
8/8/24 9:00:00 AM ET
$SEMR
$CVET
Computer Software: Prepackaged Software
Technology
Other Pharmaceuticals
Health Care
Westlake Set to Join S&P MidCap 400; MillerKnoll to Join S&P SmallCap 600
NEW YORK, Oct. 13, 2022 /PRNewswire/ -- Westlake Corp. (NYSE:WLK) will replace MillerKnoll Inc. (NASD:MLKN) in the S&P MidCap 400, and MillerKnoll will replace Covetrus Inc. (NASD:CVET) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 18. Clayton, Dubilier & Rice and TPG Capital acquired Covetrus in a deal that closed today. MillerKnoll is more representative of the small-cap market space. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector October 18, 2022 S&P MidCap 400 Addition Westlake WLK Materials S&P MidCap 400 Deletion Miller
10/13/22 5:50:00 PM ET
$CVET
$MLKN
$SPGI
$WLK
Other Pharmaceuticals
Health Care
Office Equipment/Supplies/Services
Consumer Discretionary
Covetrus Names Michelle Bonfilio as Chief People Officer
Covetrus® (NASDAQ:CVET), a global leader in animal-health technology and services, today announced the appointment of Michelle Bonfilio as Chief People Officer, reporting to Ben Wolin, President and Chief Executive Officer at Covetrus. In this role, Bonfilio will oversee the human resources and communications organizations and help shape the culture of the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220926005710/en/Michelle Bonfilio (Photo: Business Wire) "Michelle has a proven track record of empowering teams to achieve results, driving an inclusive culture and aligning purpose to the work employees do each day," sai
9/26/22 4:00:00 PM ET
$CVET
Other Pharmaceuticals
Health Care

Key Cannabis Exec Changes You Need To Know About: Leafly's New CCO, Glass House's New Appointment & More
Leafly Names New CCO Leafly Holdings, Inc. (NASDAQ:LFLY) announced that Carlos Pinto joined the company as a chief commercial officer. Pinto agreed to lead Leafly's sales, marketing and award-winning content teams as well as manage and shape the go-to-market strategy for existing and new products, sales planning and refine the company's product strategy to increase revenue generation in both existing and new markets. He brings many years of experience from his distinguished career in digital media, business development and intellectual property compliance as well as a proven track record in scaling and helping businesses mature. Yoko Miyashita, CEO of Leafly, said that the combination of
10/25/22 1:09:34 PM ET
$LFLY
$UGRO
$CVET
Computer Software: Prepackaged Software
Technology
Industrial Specialties
Consumer Discretionary
Westlake Set To Join S&P MidCap 400, Replacing MillerKnoll; MillerKnoll To Replace Coventrus In S&P SmallCap 600
Westlake Corp. (NYSE:WLK) will replace MillerKnoll Inc. (NASD:MLKN) in the S&P MidCap 400, and MillerKnoll will replace Covetrus Inc. (NASD:CVET) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 18. Clayton, Dubilier & Rice and TPG Capital acquired Covetrus in a deal that closed today. MillerKnoll is more representative of the small-cap market space
10/13/22 5:23:25 PM ET
$CVET
$MLKN
$WLK
Other Pharmaceuticals
Health Care
Office Equipment/Supplies/Services
Consumer Discretionary
Looking Into Covetrus's Return On Capital Employed
Covetrus (NASDAQ:CVET) brought in sales totaling $1.22 billion during Q2 according to data provided by Benzinga Pro. However, earnings decreased 100.0%, resulting in a loss of $4.00 million. Covetrus collected $1.15 billion in revenue during Q1, but reported earnings showed a $2.00 million loss. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q2, Co
8/22/22 9:54:05 AM ET
$CVET
Other Pharmaceuticals
Health Care

$CVET
Leadership Updates

Live Leadership Updates

Semrush Strengthens Customer Focus with Appointment of Veronique Montreuil as Chief Customer and Data Officer
Semrush (NYSE:SEMR), a leading online visibility management SaaS platform, is pleased to announce that Veronique Montreuil joins the executive team as Chief Customer and Data Officer. With over 20 years of experience in customer success and customer experience, Veronique brings a wealth of expertise to enhance customer relationships and drive growth. In her most recent role as Head of Technology Sales and Customer Success at Covetrus (NASDAQ:CVET), Veronique led a team of 275 professionals, driving operational efficiency, fostering deep customer relationships, and optimizing customer value through strategic initiatives and process improvements. She held prior roles at companies INAP (NASD
8/8/24 9:00:00 AM ET
$SEMR
$CVET
Computer Software: Prepackaged Software
Technology
Other Pharmaceuticals
Health Care
Covetrus Names Michelle Bonfilio as Chief People Officer
Covetrus® (NASDAQ:CVET), a global leader in animal-health technology and services, today announced the appointment of Michelle Bonfilio as Chief People Officer, reporting to Ben Wolin, President and Chief Executive Officer at Covetrus. In this role, Bonfilio will oversee the human resources and communications organizations and help shape the culture of the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220926005710/en/Michelle Bonfilio (Photo: Business Wire) "Michelle has a proven track record of empowering teams to achieve results, driving an inclusive culture and aligning purpose to the work employees do each day," sai
9/26/22 4:00:00 PM ET
$CVET
Other Pharmaceuticals
Health Care
Covetrus Names Margie B. Pritchard General Counsel
Covetrus® (NASDAQ:CVET), a global leader in animal-health technology and services, today announced the appointment of Margie B. Pritchard as General Counsel and Corporate Secretary, reporting to Ben Wolin, President and Chief Executive Officer (CEO) at Covetrus. Prior to being named as General Counsel, Pritchard most recently served as Vice President, Deputy Counsel at Covetrus, where she was responsible for corporate and board governance, public reporting, advising investor relations, employment matters including compensation, and providing general legal counsel to executive management. "Margie has been serving as Interim General Counsel since December 2021, and we are thrilled to have h
8/26/22 8:00:00 AM ET
$CVET
Other Pharmaceuticals
Health Care

$CVET
Financials

Live finance-specific insights

Covetrus Announces Financial Results for Second Quarter of 2022
Second quarter 2022 net sales of $1.22 billion, an increase of 2% year-over-year; GAAP net loss attributable to Covetrus of $(4) million Non-GAAP organic net sales growth of 5% year-over-year Non-GAAP adjusted EBITDA was flat year-over-year at $66 million, including a $2 million year-over-year headwind from the strengthening of the U.S. Dollar First half 2022 net sales of $2.37 billion, an increase of 3% year-over-year; GAAP net loss attributable to Covetrus of $(6) million Non-GAAP organic net sales growth of 6% year-over-year Non-GAAP adjusted EBITDA increased 5% year-over-year to $129 million, including a $4 million year-over-year headwind from the strengthening of the U.S.
8/4/22 8:00:00 AM ET
$CVET
Other Pharmaceuticals
Health Care
Covetrus Announces First Quarter 2022 Earnings Release Date and Conference Call Information
Covetrus® (NASDAQ:CVET), a global leader in animal-health technology and services, announced today that it will release first quarter 2022 results after the market closes on Thursday, May 5, 2022. Following the release, the Company will hold a conference call at 4:30 PM ET, during which Ben Wolin, president and chief executive officer, and Matthew Foulston, executive vice president and chief financial officer, will review the results. To access the live webcast of the conference call and the corresponding slide presentation, individuals can register at our Investor Relations site: https://ir.covetrus.com/investors/events-and-presentations. An archived edition of the conference call will be
4/29/22 8:00:00 AM ET
$CVET
Other Pharmaceuticals
Health Care
Covetrus Announces Financial Results for Fourth Quarter and Full-Year of 2021
Fourth quarter 2021 net sales of $1.12 billion, unchanged year-over-year; GAAP net loss attributable to Covetrus of $(3) million Non-GAAP organic net sales growth of 2% year-over-year Non-GAAP adjusted EBITDA increased 13% year-over-year to $63 million Full-year 2021 net sales of $4.58 billion, an increase of 5% year-over-year; GAAP net loss attributable to Covetrus of $(54) million Non-GAAP organic net sales growth of 5% year-over-year Non-GAAP adjusted EBITDA increased 8% year-over-year to $244 million 2022 non-GAAP organic net sales growth guidance of 7% to 8% and non-GAAP adjusted EBITDA guidance in the range of $270 million to $280 million Covetrus® (NASDAQ:CVET), a
2/24/22 4:01:00 PM ET
$CVET
Other Pharmaceuticals
Health Care

UPDATE: Covetrus Q2 Adj. EPS $0.26 Beats $0.25 Estimate, Sales $1.22B Miss $1.22B Estimate

Chat with this insight

Recent Analyst Ratings for $CVET

$CVET Press Releases

Fastest customizable press release news feed in the world

Semrush Strengthens Customer Focus with Appointment of Veronique Montreuil as Chief Customer and Data Officer

Westlake Set to Join S&P MidCap 400; MillerKnoll to Join S&P SmallCap 600

Covetrus Names Michelle Bonfilio as Chief People Officer

$CVET SEC Filings

SEC Form 15-12G filed by Covetrus Inc.

SEC Form S-8 POS filed by Covetrus Inc.

SEC Form SC 13E3/A filed by Covetrus Inc. (Amendment)

$CVET Market Insights

Live Market Insights

Key Cannabis Exec Changes You Need To Know About: Leafly's New CCO, Glass House's New Appointment & More

Westlake Set To Join S&P MidCap 400, Replacing MillerKnoll; MillerKnoll To Replace Coventrus In S&P SmallCap 600

Looking Into Covetrus's Return On Capital Employed

$CVET Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13D/A filed by Covetrus Inc. (Amendment)

SEC Form SC 13D/A filed by Covetrus Inc. (Amendment)

SEC Form SC 13D/A filed by Covetrus Inc. (Amendment)

$CVET Leadership Updates

Live Leadership Updates

Semrush Strengthens Customer Focus with Appointment of Veronique Montreuil as Chief Customer and Data Officer

Covetrus Names Michelle Bonfilio as Chief People Officer

Covetrus Names Margie B. Pritchard General Counsel

$CVET Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Covetrus downgraded by Stifel with a new price target

Covetrus downgraded by Raymond James

Morgan Stanley initiated coverage on Covetrus with a new price target

$CVET Financials

Live finance-specific insights

Covetrus Announces Financial Results for Second Quarter of 2022

Covetrus Announces First Quarter 2022 Earnings Release Date and Conference Call Information

Covetrus Announces Financial Results for Fourth Quarter and Full-Year of 2021

$CVET Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4: Cd&R Investment Associates Ix, Ltd. disposed of 33,670,541 shares

SEC Form 4: Helton Sandra L returned 38,095 shares to the company, closing all direct ownership in the company

SEC Form 4: Laskawy Philip A returned 15,064 shares to the company, closing all direct ownership in the company

Recent Analyst Ratings for
$CVET

$CVET
Press Releases

$CVET
SEC Filings

$CVET
Market Insights

$CVET
Large Ownership Changes

$CVET
Leadership Updates

$CVET
Analyst Ratings

$CVET
Financials

$CVET
Insider Trading